Nitrase Therapeutics
USNitrase Therapeutics is a healthcare / biotech company, headquartered in United States.
Entry
2020
Hold
6yr
Status
Active
Est. EV
–
Key facts
HQUnited States
SectorHealthcare / Biotech
US company deploying its NITROME platform to develop therapies targeting nitrases, a novel class of enzymes discovered by the company.
See the full ownership history.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Full fund context: vintage, strategy, region
Already a member? Sign in
More from Sofinnova Capital IX
Other portfolio companies in the same fund.
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
France
BelgiumLast updated April 2026 · Sourced from public filings
Italy
UK